Pages that link to "Q35012646"

The following pages link to Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study (Q35012646):

Displaying 40 items.

• The brain mineralocorticoid receptor and stress resilience (Q26829127) (← links)
• The ubiquitous mineralocorticoid receptor: clinical implications (Q26861721) (← links)
• Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis (Q26995642) (← links)
• Genetic Moderation of Stress Effects on Corticolimbic Circuitry (Q28606435) (← links)
• Cortisol’s effects on hippocampal activation in depressed patients are related to alterations in memory formation (Q30498379) (← links)
• Biomarkers for depression: recent insights, current challenges and future prospects (Q33704099) (← links)
• The role of mineralocorticoid receptor function in treatment-resistant depression (Q34361037) (← links)
• Early-life stress and HPA axis trigger recurrent adulthood depression. (Q34387331) (← links)
• Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule? (Q35118620) (← links)
• Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus (Q35190097) (← links)
• A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory. (Q35592045) (← links)
• Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals (Q35647316) (← links)
• A common and functional mineralocorticoid receptor haplotype enhances optimism and protects against depression in females. (Q35844146) (← links)
• The multifaceted mineralocorticoid receptor (Q35906989) (← links)
• Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders (Q36410269) (← links)
• Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth? (Q36437145) (← links)
• The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment (Q36442015) (← links)
• Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review (Q36772974) (← links)
• The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. (Q36787614) (← links)
• Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. (Q36901146) (← links)
• Metyrapone in treatment-resistant depression (Q37079032) (← links)
• Early Life Stress in Depressive Patients: HPA Axis Response to GR and MR Agonist. (Q37510945) (← links)
• HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition (Q37647371) (← links)
• HPA axis alterations in mental disorders: impact on memory and its relevance for therapeutic interventions (Q37818507) (← links)
• Role of mineralocorticoid receptors on the hypothalamus-pituitary-adrenal axis in humans (Q38029960) (← links)
• Corticosteroid receptor signalling modes and stress adaptation in the brain (Q38471565) (← links)
• The link between depression and diabetes: the search for shared mechanisms (Q38494723) (← links)
• Stress and Depression: a Crucial Role of the Mineralocorticoid Receptor. (Q38771510) (← links)
• Assessment of the hypothalamic-pituitary-adrenal axis activity: glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress - a systematic review. (Q39128695) (← links)
• Association between cortisol awakening response and memory function in major depression (Q48148070) (← links)
• Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study (Q48684809) (← links)
• Depression and the hypothalamic-pituitary-adrenal axis: increasing the scope. (Q48742074) (← links)
• Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation (Q50082429) (← links)
• Major depressive disorder (Q56962426) (← links)
• Mechanistic Insights in NeuroD Potentiation of Mineralocorticoid Receptor Signaling (Q64103333) (← links)
• Glucocorticoid Negative Feedback in Regulation of the Hypothalamic-Pituitary-Adrenal Axis in Rhesus Monkeys With Various Types of Adaptive Behavior: Individual and Age-Related Differences (Q64257577) (← links)
• Association of a common mineralocorticoid receptor gene polymorphism with salivary cortisol in healthy adults (Q85015550) (← links)
• Glucocorticoid and Mineralocorticoid Receptors in the Brain: A Transcriptional Perspective (Q90621430) (← links)
• Top-down and bottom-up control of stress-coping (Q90712990) (← links)
• Cognitive and emotional empathy after stimulation of brain mineralocorticoid and NMDA receptors in patients with major depression and healthy controls (Q98156746) (← links)